Top Markets
Coin of the day
Crescent Biopharma, Inc. Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
Rangering i aksjer #11763
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and... Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Aksjekurs
$17.81
Sist synkronisert: 2026-08-28
Markedsverdi
$661.63M
Endring (1 dag)
0.30%
Endring (1 år)
23.70%
Land
US
Handel Crescent Biopharma, Inc. (CBIO)

Kategori

Historikk for aksjesplitt for Crescent Biopharma, Inc. (CBIO)
Aksjen Crescent Biopharma, Inc. (symbol: CBIO) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 30, 2026.
Én CBIO-aksje kjøpt før Aug 30, 2026 tilsvarer i dag 0 CBIO-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH